申请人:Cowley Martin Phillip
公开号:US20050250760A1
公开(公告)日:2005-11-10
The present invention relates to 1-[(indol-3-yl)carbonyl]piperazine derivative according to the general formula I
or a pharmaceutically acceptable salt thereof. The invention also relates to pharmaceutical compositions comprising said 1-[(indol-3-yl)carbonyl]piperazine derivatives, and to the use of these derivatives in the treatment of pain, such as peri-operative pain, chronic pain neuropathic pain, cancer pain, and pain and spasticity associated with multiple sclerosis.
本发明涉及一种符合通式I的1-[(indol-3-yl)carbonyl]piperazine衍生物,或其药学上可接受的盐。本发明还涉及包含上述1-[(indol-3-yl)carbonyl]piperazine衍生物的药物组合物,以及利用这些衍生物治疗疼痛,例如围手术期疼痛、慢性疼痛、神经病理性疼痛、癌症疼痛以及与多发性硬化相关的疼痛和痉挛。